Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
An all-inclusive program, like ours, bundles the more affordable compounded medication and all clinical support into one predictable price
Relevant Updates to the Interim Bulk Drug Substances List for 503A Pharmacies 2,4,5,6 For a full list of updates, please download the complete Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act document linked above
Self-Pay with Program Discounts Choose longer program durations (8-week or 12-week plans) to get the lowest monthly cost
If you want to find out whether you may qualify for a personalized program, take the free assessment quiz and review your next steps with a licensed provider
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients
